Cargando…

The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics

Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Han, Tseng, Watson Hua-Sheng, Chi, Jen-Tsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464484/
https://www.ncbi.nlm.nih.gov/pubmed/32718025
http://dx.doi.org/10.3390/biology9080187
_version_ 1783577376195608576
author Chen, Po-Han
Tseng, Watson Hua-Sheng
Chi, Jen-Tsan
author_facet Chen, Po-Han
Tseng, Watson Hua-Sheng
Chi, Jen-Tsan
author_sort Chen, Po-Han
collection PubMed
description Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have identified intricate and complicated interplay between ferroptosis, ionizing radiation (IR), ATM (ataxia–telangiectasia mutated)/ATR (ATM and Rad3-related), and tumor suppressor p53, which signifies the participation of the DNA damage response (DDR) in iron-related cell death. DDR is an evolutionarily conserved response triggered by various DNA insults to attenuate proliferation, enable DNA repairs, and dispose of cells with damaged DNA to maintain genome integrity. Deficiency in proper DDR in many genetic disorders or tumors also highlights the importance of this pathway. In this review, we will focus on the biological crosstalk between DDR and ferroptosis, which is mediated mostly via noncanonical mechanisms. For clinical applications, we also discuss the potential of combining ionizing radiation and ferroptosis-inducers for synergistic effects. At last, various ATM/ATR inhibitors under clinical development may protect ferroptosis and treat many ferroptosis-related diseases to prevent cell death, delay disease progression, and improve clinical outcomes.
format Online
Article
Text
id pubmed-7464484
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74644842020-09-04 The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics Chen, Po-Han Tseng, Watson Hua-Sheng Chi, Jen-Tsan Biology (Basel) Review Ferroptosis is a novel form of iron-dependent cell death characterized by lipid peroxidation. While the importance and disease relevance of ferroptosis are gaining recognition, much remains unknown about its interaction with other biological processes and pathways. Recently, several studies have identified intricate and complicated interplay between ferroptosis, ionizing radiation (IR), ATM (ataxia–telangiectasia mutated)/ATR (ATM and Rad3-related), and tumor suppressor p53, which signifies the participation of the DNA damage response (DDR) in iron-related cell death. DDR is an evolutionarily conserved response triggered by various DNA insults to attenuate proliferation, enable DNA repairs, and dispose of cells with damaged DNA to maintain genome integrity. Deficiency in proper DDR in many genetic disorders or tumors also highlights the importance of this pathway. In this review, we will focus on the biological crosstalk between DDR and ferroptosis, which is mediated mostly via noncanonical mechanisms. For clinical applications, we also discuss the potential of combining ionizing radiation and ferroptosis-inducers for synergistic effects. At last, various ATM/ATR inhibitors under clinical development may protect ferroptosis and treat many ferroptosis-related diseases to prevent cell death, delay disease progression, and improve clinical outcomes. MDPI 2020-07-23 /pmc/articles/PMC7464484/ /pubmed/32718025 http://dx.doi.org/10.3390/biology9080187 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chen, Po-Han
Tseng, Watson Hua-Sheng
Chi, Jen-Tsan
The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title_full The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title_fullStr The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title_full_unstemmed The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title_short The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
title_sort intersection of dna damage response and ferroptosis—a rationale for combination therapeutics
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464484/
https://www.ncbi.nlm.nih.gov/pubmed/32718025
http://dx.doi.org/10.3390/biology9080187
work_keys_str_mv AT chenpohan theintersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics
AT tsengwatsonhuasheng theintersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics
AT chijentsan theintersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics
AT chenpohan intersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics
AT tsengwatsonhuasheng intersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics
AT chijentsan intersectionofdnadamageresponseandferroptosisarationaleforcombinationtherapeutics